Prothena Corporation plc
PRTA
$10.48
-$0.36-3.32%
Weiss Ratings | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.13 | |||
Price History | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -20.24% | |||
30-Day Total Return | -28.37% | |||
60-Day Total Return | -19.69% | |||
90-Day Total Return | -30.50% | |||
Year to Date Total Return | -23.34% | |||
1-Year Total Return | -55.74% | |||
2-Year Total Return | -78.54% | |||
3-Year Total Return | -71.33% | |||
5-Year Total Return | -5.50% | |||
52-Week High % Change | -57.36% | |||
52-Week Low % Change | 8.40% | |||
Price | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $25.42 | |||
52-Week Low Price | $10.00 | |||
52-Week Low Price (Date) | Apr 07, 2025 | |||
52-Week High Price (Date) | Jul 25, 2024 | |||
Valuation | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 583.48M | |||
Enterprise Value | 122.94M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.30 | |||
Earnings Per Share Growth | -17.79% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 4.32 | |||
Price/Book (Q) | 1.20 | |||
Enterprise Value/Revenue (TTM) | 0.91 | |||
Price | $10.48 | |||
Enterprise Value/EBITDA (TTM) | -0.80 | |||
Enterprise Value/EBIT | -0.80 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 53.82M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 353 1 236 2500 | |||
Address | -- | |||
Website | www.prothena.com | |||
Country | Ireland | |||
Year Founded | 2012 | |||
Profitability | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -114.35% | |||
Profit Margin | -90.49% | |||
Management Effectiveness | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -15.54% | |||
Return on Equity | -- | |||
Income Statement | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 135.16M | |||
Total Revenue (TTM) | 135.16M | |||
Revenue Per Share | $2.51 | |||
Gross Profit (TTM) | -87.36M | |||
EBITDA (TTM) | -153.67M | |||
EBIT (TTM) | -154.56M | |||
Net Income (TTM) | -122.31M | |||
Net Income Avl. to Common (TTM) | -122.31M | |||
Total Revenue Growth (Q YOY) | 571.84% | |||
Earnings Growth (Q YOY) | 14.11% | |||
EPS Diluted (TTM) | -2.30 | |||
EPS Diluted Growth (Q YOY) | 14.35% | |||
Balance Sheet | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 471.39M | |||
Cash Per Share (Q) | $8.76 | |||
Total Current Assets (Q) | 485.41M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 486.93M | |||
Current Ratio (Q) | 10.008 | |||
Book Value Per Share (Q) | $9.05 | |||
Total Assets (Q) | 547.11M | |||
Total Current Liabilities (Q) | 48.50M | |||
Total Debt (Q) | 10.84M | |||
Total Liabilities (Q) | 60.18M | |||
Total Common Equity (Q) | 486.93M | |||
Cash Flow | PRTA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -298.00K | |||
Cash from Financing (TTM) | 1.55M | |||
Net Change in Cash (TTM) | -148.79M | |||
Levered Free Cash Flow (TTM) | -53.50M | |||
Cash from Operations (TTM) | -150.05M | |||